To demonstrate that it is possible to monitor the response to adjuvant therapy by repeated analysis of circulating epithelial tumor cells (CETCs) and to detect patients early who are at risk of relapse.
Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse.
Department of Experimental Hematology and Oncology, Clinic for Internal Medicine II, Friedrich Schiller Universität Jena, Erlanger Allee 101, D-07747, Jena, Germany. katharina.pachmann@med.uni-jena.de
